These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8820848)

  • 1. Atrial defibrillation: can modifications in current implantable cardioverter-defibrillators achieve this?
    Heisel A; Jung J; Fries R; Schieffer H; Ozbek C
    Am J Cardiol; 1996 Sep; 78(5A):119-27. PubMed ID: 8820848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The atrial defibrillator: a stand-alone device or part of a combined dual-chamber system?
    Heisel A; Jung J
    Am J Cardiol; 1999 Mar; 83(5B):218D-226D. PubMed ID: 10089869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atrial defibrillators].
    Heisel A; Jung J; Buob A; Siaplaouras S
    Z Kardiol; 2000; 89 Suppl 10():35-41; discussion 41-2. PubMed ID: 11151773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atrial defibrillator].
    Jung W; Lüderitz B
    Z Kardiol; 2000; 89 Suppl 3():206-14. PubMed ID: 10810804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atrial defibrillator].
    Jung W; Lüderitz B
    Herz; 1998 Jun; 23(4):251-9. PubMed ID: 9690112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable atrial defibrillators.
    Hillsley RE; Wharton JM
    J Cardiovasc Electrophysiol; 1995 Aug; 6(8):634-48. PubMed ID: 8535562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internal defibrillation: where we have been and where we should be going?
    Lévy S
    J Interv Card Electrophysiol; 2005 Aug; 13 Suppl 1():61-6. PubMed ID: 16133857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
    Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
    Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of sinus rhythm return during defibrillation testing in patients with permanent atrial fibrillation undergoing implantation of a cardioverter-defibrillator.
    Lelakowski J; Tomala I; Cmiel A; Rydlewska A; Majewski J; Małecka B
    Kardiol Pol; 2011; 69(1):17-22. PubMed ID: 21267958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transvenous atrial cardioversion threshold in patients with implantable cardioverter defibrillator: influence of active pectoral can.
    Heisel A; Jung J; Nikoloudakis N; Fries R; Schäfers HJ; Schieffer H
    Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 2):253-7. PubMed ID: 9990641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future prospects for implantable devices for atrial defibrillation.
    Tse HF; Lau CP
    Cardiol Clin; 2004 Feb; 22(1):87-100, ix. PubMed ID: 14994850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracardiac atrial defibrillation.
    Dosdall DJ; Ideker RE
    Heart Rhythm; 2007 Mar; 4(3 Suppl):S51-6. PubMed ID: 17336885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial defibrillation. New frontiers.
    Carlson MD; Biblo LA
    Cardiol Clin; 1996 Nov; 14(4):607-22. PubMed ID: 8950061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific considerations with the automatic implantable atrial defibrillator.
    Jung W; Wolpert C; Esmailzadeh B; Spehl S; Herwig S; Schumacher B; Lewalter T; Omran H; Kirchhoff PG; Lüderitz B
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S193-201. PubMed ID: 9727697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient experiences with atrial fibrillation and treatment with implantable atrial defibrillation therapy.
    Deaton C; Dunbar SB; Moloney M; Sears SF; Ujhelyi MR
    Heart Lung; 2003; 32(5):291-9. PubMed ID: 14528186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future role of defibrillators in the management of atrial fibrillation.
    Ayers GM; Griffin JC
    Curr Opin Cardiol; 1997 Jan; 12(1):12-7. PubMed ID: 9132075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Return of sinus rhythm in permanent atrial fibrillation patients at the time of the testing defibrillation during cardioverter-defibrillator implantation].
    Lelakowski J; Rydlewska A; Tomala I; Majewski J; Małecka B; Kuniewicz M
    Pol Merkur Lekarski; 2010 Aug; 29(170):84-7. PubMed ID: 20842818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intra-atrial defibrillation--limits and possibilities].
    Jung W; Lüderitz B
    Z Kardiol; 1996; 85 Suppl 6():75-81. PubMed ID: 9064986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial defibrillation with a transvenous lead: a randomized comparison of active can shocking pathways.
    Cooklin M; Olsovsky MR; Brockman RG; Shorofsky SR; Gold MR
    J Am Coll Cardiol; 1999 Aug; 34(2):358-62. PubMed ID: 10440146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.